1.74
price down icon3.33%   -0.06
after-market Handel nachbörslich: 1.75 0.01 +0.57%
loading

Finanzdaten der Invivyd Inc-Aktie (IVVD)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
31.06%
17.21
13.13 11.79 11.30 13.82
Operating Expenses
23.23%
29.76
24.15 26.85 28.23 33.05
Benefits Costs and Expenses
17.08%
28.28
24.15 26.85 27.59 32.26
Costs And Expenses
23.23%
29.76
24.15 26.85 28.23 33.05
Operating Income/Loss
13.90%
-12.55
-11.02 -15.06 -16.92 -19.23
Nonoperating Income/Loss
168.54%
1.485
0.553 0.40 0.633 0.786
Income/Loss From Continuing Operations Before Tax
0.43%
-11.07
-11.02 -14.66 -16.29 -18.44
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
5.73%
-11.07
-10.47 -14.66 -16.29 -18.44
Net Income/Loss
5.73%
-11.07
-10.47 -14.66 -16.29 -18.44
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
79.23%
35.34
170.17 120.02 119.88 0.3915
Diluted Average Shares
79.23%
35.34
170.17 120.02 119.88 0.3915
Basic Earnings Per Share
100.00%
-
-0.06 -0.12 -0.14 -0.15
Diluted Earnings Per Share
100.00%
-
-0.06 -0.12 -0.14 -0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):